SanBio Company Limited

4592 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥922.00
-1.91%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.15.
  • Current assets comfortably cover current liabilities (current ratio 28.99).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -652.1 times.
  • Return on equity is on the lower side at -19.7%.
  • Return on capital employed is on the lower side at -25.2%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.26

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥720億
Current Price¥ 922.00
High / Low¥ 3,990.00 / 874.00
Stock P/E-17.55
Book Value¥ 170.93
Dividend Yield0%
ROCE-25.15%
ROE-19.74%
Debt to Equity0.15
Current Ratio28.99
P/B Ratio5.6767807
EPS¥ -52.55
ICR-652.14
Educational data only. Not a recommendation to buy, sell or hold any security.